ATE142501T1 - Verwendung von 1-(beta-d-arabinofuranosyl)-5- propynyluracil zur senkung des serumcholesterins - Google Patents
Verwendung von 1-(beta-d-arabinofuranosyl)-5- propynyluracil zur senkung des serumcholesterinsInfo
- Publication number
- ATE142501T1 ATE142501T1 AT92910638T AT92910638T ATE142501T1 AT E142501 T1 ATE142501 T1 AT E142501T1 AT 92910638 T AT92910638 T AT 92910638T AT 92910638 T AT92910638 T AT 92910638T AT E142501 T1 ATE142501 T1 AT E142501T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- propynyluracil
- arabinofuranosyl
- beta
- serum cholesterol
- Prior art date
Links
- QLOCVMVCRJOTTM-SDNRWEOFSA-N 1-[(2r,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-1-ynylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C#CC)=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 QLOCVMVCRJOTTM-SDNRWEOFSA-N 0.000 title abstract 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title abstract 2
- 108010028554 LDL Cholesterol Proteins 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919111580A GB9111580D0 (en) | 1991-05-30 | 1991-05-30 | Nucleoside derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE142501T1 true ATE142501T1 (de) | 1996-09-15 |
Family
ID=10695778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92910638T ATE142501T1 (de) | 1991-05-30 | 1992-05-29 | Verwendung von 1-(beta-d-arabinofuranosyl)-5- propynyluracil zur senkung des serumcholesterins |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5432166A (de) |
| EP (1) | EP0542952B1 (de) |
| JP (1) | JPH06500129A (de) |
| AT (1) | ATE142501T1 (de) |
| AU (1) | AU657756B2 (de) |
| CA (1) | CA2088264A1 (de) |
| DE (1) | DE69213660D1 (de) |
| GB (1) | GB9111580D0 (de) |
| HU (1) | HUT63767A (de) |
| IE (1) | IE921731A1 (de) |
| IL (1) | IL102058A (de) |
| MX (1) | MX9202595A (de) |
| WO (1) | WO1992021352A1 (de) |
| ZA (1) | ZA923962B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6753006B1 (en) | 1993-02-22 | 2004-06-22 | American Bioscience, Inc. | Paclitaxel-containing formulations |
| US20030054042A1 (en) * | 2001-09-14 | 2003-03-20 | Elaine Liversidge | Stabilization of chemical compounds using nanoparticulate formulations |
| AU2003230691A1 (en) * | 2002-03-20 | 2003-10-08 | Elan Pharma International Ltd. | Nanoparticulate compositions of angiogenesis inhibitors |
| SG10201610936RA (en) | 2011-12-22 | 2017-02-27 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2244328A1 (de) * | 1972-09-09 | 1974-03-21 | Boehringer Mannheim Gmbh | Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben |
| US4594339A (en) * | 1982-04-06 | 1986-06-10 | Sloan-Kettering Institute For Cancer Research | Anti-herpes virus compositions containing 5-substituted 1-2'(deoxy-2-'-substituted-β-d-arabinofuranosyl)pyrimedene nucleosides |
| IT1196261B (it) * | 1984-09-20 | 1988-11-16 | Pierrel Spa | Derivati nucleosidici e purinici 8-sostituiti |
| US5063233A (en) * | 1986-11-14 | 1991-11-05 | Ciba-Geigy Corporation | N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists |
| GB8629892D0 (en) * | 1986-12-15 | 1987-01-28 | Wellcome Found | Antiviral compounds |
| NL8702926A (nl) * | 1986-12-15 | 1988-07-01 | Sandoz Ag | Nieuwe furanuronzuurderivaten en werkwijzen voor het bereiden en toepassen van deze derivaten. |
| EP0277917A3 (de) * | 1987-02-04 | 1990-03-28 | Ciba-Geigy Ag | Bestimmte Derivate von Adenosin-5'-carboxamid |
| US4962194A (en) * | 1987-04-02 | 1990-10-09 | Warner-Lambert Company | Method of preparing 51,N6-disubstituted adenosines from inosines |
| US5028596A (en) * | 1987-12-14 | 1991-07-02 | Burroughs Wellcome Co. | 1-(β-D-arabinofuranosyl)-5-propynyluracil for treatment of VZV infections |
| GB8729994D0 (en) * | 1987-12-23 | 1988-02-03 | Glaxo Group Ltd | Chemical compounds |
| AU3820989A (en) * | 1988-08-02 | 1990-02-08 | Ciba-Geigy Ag | 7-amino-3-beta-d-ribofuranosyl-3h-imidazo(4,5-b) pyridin-5-amine derivatives |
| GB2226027B (en) * | 1988-12-13 | 1992-05-20 | Sandoz Ltd | Adenosine derivatives,their production and use |
| JPH03287537A (ja) * | 1990-03-31 | 1991-12-18 | Yamasa Shoyu Co Ltd | 抗動脈硬化症剤 |
| FR2665362B1 (fr) * | 1990-08-03 | 1994-12-09 | Cepbepe | Substance contenant, comme principe actif, une adenosine substitutee en n6 et son application. |
-
1991
- 1991-05-30 GB GB919111580A patent/GB9111580D0/en active Pending
-
1992
- 1992-05-29 JP JP4509647A patent/JPH06500129A/ja active Pending
- 1992-05-29 US US07/988,122 patent/US5432166A/en not_active Expired - Fee Related
- 1992-05-29 ZA ZA923962A patent/ZA923962B/xx unknown
- 1992-05-29 HU HU9300243A patent/HUT63767A/hu unknown
- 1992-05-29 AU AU17673/92A patent/AU657756B2/en not_active Ceased
- 1992-05-29 CA CA002088264A patent/CA2088264A1/en not_active Abandoned
- 1992-05-29 IL IL10205892A patent/IL102058A/en active IP Right Grant
- 1992-05-29 EP EP92910638A patent/EP0542952B1/de not_active Expired - Lifetime
- 1992-05-29 WO PCT/GB1992/000971 patent/WO1992021352A1/en not_active Ceased
- 1992-05-29 AT AT92910638T patent/ATE142501T1/de not_active IP Right Cessation
- 1992-05-29 DE DE69213660T patent/DE69213660D1/de not_active Expired - Lifetime
- 1992-05-29 MX MX9202595A patent/MX9202595A/es unknown
- 1992-07-01 IE IE173192A patent/IE921731A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0542952B1 (de) | 1996-09-11 |
| HU9300243D0 (en) | 1993-04-28 |
| US5432166A (en) | 1995-07-11 |
| CA2088264A1 (en) | 1992-12-01 |
| JPH06500129A (ja) | 1994-01-06 |
| WO1992021352A1 (en) | 1992-12-10 |
| IE921731A1 (en) | 1992-12-02 |
| AU1767392A (en) | 1993-01-08 |
| IL102058A (en) | 1996-07-23 |
| AU657756B2 (en) | 1995-03-23 |
| HUT63767A (en) | 1993-10-28 |
| MX9202595A (es) | 1992-11-01 |
| EP0542952A1 (de) | 1993-05-26 |
| ZA923962B (en) | 1993-11-29 |
| DE69213660D1 (de) | 1996-10-17 |
| IL102058A0 (en) | 1992-12-30 |
| GB9111580D0 (en) | 1991-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69814394D1 (de) | Verwendung von levobupivacain | |
| EP0831882A4 (de) | Zusammensetzungen aus rekonstituierten kollagenfasersegmenten und verfahren zu ihrer herstellung | |
| FI883653L (fi) | Mikrobeja tappava mikroemulsio | |
| IS2118B (is) | Aðferðir til að kalla fram T-eitilfrumu þol í ígræddum vef eða líffæri | |
| ATE288273T1 (de) | Verwendung von uridin-5'-diphosphat und analoge zur behandlung von lungenerkrankungen | |
| SE9604793L (sv) | Nya Kristallmodifikationer | |
| NO891909D0 (no) | Implantat for brytningskorreksjon i et oeyes forkammer. | |
| AU6788794A (en) | Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant | |
| DE69326776D1 (de) | Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress | |
| DE69625696D1 (de) | Verwendung eines thienotriazoldiazepins zur erhöhung des apolopoproteins a-i niveaus | |
| ATE218350T1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
| AU3078892A (en) | Human interleukin-8 analogs | |
| BR9608100A (pt) | Pirazolo[1,5a] pirimidina processos para a sua preparação e para o controle e fungos nocivos e pragas composição e utilização dos compostos | |
| ATE240730T1 (de) | Verwendung von levobupivacaine in gesichtschirugie | |
| DE59507755D1 (de) | Dipeptidische p-amidinobenzylamide mit n-terminalen sulfonyl- bzw. aminosulfonylresten | |
| DE59308848D1 (de) | Anwendung von urodilatin bei lungen- und bronchialerkrankungen | |
| ATE307203T1 (de) | Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma | |
| DE69811248D1 (de) | Verwendung eines 5ht2 rezeptor-antagonisten zur behandlung von schlafapnoe | |
| DE69213660D1 (de) | Verwendung von 1-(beta-d-arabinofuranosyl)-5-propynyluracil zur senkung des serumcholesterins | |
| DE69328193D1 (de) | Verwendung von prodelphidinen zur behandlung von arthrose | |
| DE69330680D1 (de) | Verwendung von 17 Alpha - Dihydroequilenin zur Senkung des Cholesterinspiegels | |
| ATE201680T1 (de) | 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze | |
| IL106237A0 (en) | Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis | |
| EA199700136A1 (ru) | Способы ингибирования экзогенных эстрогенов | |
| NO925048D0 (no) | Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |